Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Moving Pharmacogenetics Into Practice: It’s All About the Evidence!
Jasmine A. Luzum, Natasha Petry, Annette K. Taylor, et al.
Clinical Pharmacology & Therapeutics (2021) Vol. 110, Iss. 3, pp. 649-661
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Pharmacogenomics in practice: a review and implementation guide
Danya Kabbani, Reem Akika, Ahmed Wahid, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 53
Advancing Pharmacogenomics from Single-Gene to Preemptive Testing
Cyrine E. Haidar, Kristine R. Crews, James M. Hoffman, et al.
Annual Review of Genomics and Human Genetics (2022) Vol. 23, Iss. 1, pp. 449-473
Open Access | Times Cited: 35
Recommendations for pharmacogenetic testing in clinical practice guidelines in the US
Daniel L. Hertz, Chad A. Bousman, Howard L. McLeod, et al.
American Journal of Health-System Pharmacy (2024) Vol. 81, Iss. 16, pp. 672-683
Closed Access | Times Cited: 8
Clinical Pharmacogenetics of Angiotensin II Receptor Blockers in Iraq
Hany Akeel Al-Hussaniy, Alaa Fadhel Hassan, Amjad I. Oraibi, et al.
Journal of Pharmacy And Bioallied Sciences (2023) Vol. 15, Iss. 3, pp. 101-106
Open Access | Times Cited: 15
Exploring the impact of pharmacogenetics on personalized medicine: A systematic review
Laura Amaro-Álvarez, Jaime Ramos, Miguel Ángel Calleja‐Hernández
Farmacia Hospitalaria (2024) Vol. 48, Iss. 6, pp. 299-309
Open Access | Times Cited: 6
Development of a Multifaceted Program for Pharmacogenetics Adoption at an Academic Medical Center: Practical Considerations and Lessons Learned
Tyler Shugg, Emma M. Tillman, Amy M. Breman, et al.
Clinical Pharmacology & Therapeutics (2024) Vol. 116, Iss. 4, pp. 914-931
Open Access | Times Cited: 5
Clinical Implementation of DPYD Pharmacogenetic Testing to Prevent Early-Onset Fluoropyrimidine-Related Toxicity in Cancer Patients in Switzerland
Ursina B. M. Begré, Markus Jörger, Stefan Aebi, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 21
Impact of Pharmacogenomics in Clinical Practice
Nicola Principi, Kyriakoula Petropulacos, Susanna Esposito
Pharmaceuticals (2023) Vol. 16, Iss. 11, pp. 1596-1596
Open Access | Times Cited: 11
Pharmacogenetic Influences on Individual Responses to Ocular Hypotensive Agents in Glaucoma Patients
Sara Labay-Tejado, Virginia Fortuna, Néstor Ventura-Abreu, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 325-325
Open Access
The Perceived Value of Pharmacogenetic Testing in Depression Treatment: Mixed-Methods Results From the PRIME Care Study
Bonnie M. Vest, Laura O. Wray, Leland E. Hull, et al.
Psychiatric Services (2025)
Closed Access
Challenges of pediatric pharmacotherapy: A narrative review of pharmacokinetics, pharmacodynamics, and pharmacogenetics
Hirofumi Watanabe, Nobuhiko Nagano, Yasuhiro Tsuji, et al.
European Journal of Clinical Pharmacology (2023) Vol. 80, Iss. 2, pp. 203-221
Closed Access | Times Cited: 9
Approaches and hurdles of implementing pharmacogenetic testing in the psychiatric clinic
Abdullah Al Maruf, Chad A. Bousman
Psychiatry and Clinical Neurosciences Reports (2022) Vol. 1, Iss. 2
Closed Access | Times Cited: 14
Pharmacogenomic Testing for Major Depression: A Qualitative Study of the Perceptions of People with Lived Experience and Professional Stakeholders
Caitlin Slomp, Emily Morris, Louisa Edwards, et al.
The Canadian Journal of Psychiatry (2022) Vol. 68, Iss. 6, pp. 436-452
Open Access | Times Cited: 13
An Introductory Tutorial on Cardiovascular Pharmacogenetics for Healthcare Providers
Akinyemi Oni‐Orisan, Sony Tuteja, Glenda Hoffecker, et al.
Clinical Pharmacology & Therapeutics (2023) Vol. 114, Iss. 2, pp. 275-287
Open Access | Times Cited: 8
Modern developments in germline pharmacogenomics for oncology prescribing
Natalie Reizine, Peter H. O’Donnell
CA A Cancer Journal for Clinicians (2022) Vol. 72, Iss. 4, pp. 315-332
Open Access | Times Cited: 12
Genetic risk factors for drug-induced long QT syndrome: findings from a large real-world case–control study
Ana I Lopez-Medina, Alessandra M. Campos‐Staffico, C. Anwar A. Chahal, et al.
Pharmacogenomics (2024) Vol. 25, Iss. 3, pp. 117-131
Closed Access | Times Cited: 2
The Pharmacogenomics Global Research Network Implementation Working Group: global collaboration to advance pharmacogenetic implementation
Larisa H. Cavallari, J. Kevin Hicks, Jai N. Patel, et al.
Pharmacogenetics and Genomics (2024) Vol. 35, Iss. 1, pp. 1-11
Closed Access | Times Cited: 2
Defining Clinical Utility of Germline Indicators of Toxicity Risk: A Perspective
Daniel L. Hertz, Lisa M. McShane, Daniel F. Hayes
Journal of Clinical Oncology (2022) Vol. 40, Iss. 16, pp. 1721-1731
Open Access | Times Cited: 11
Receptor Pharmacogenomics: Deciphering Genetic Influence on Drug Response
Sorina Andreea Anghel, Cristina-Elena Dinu-Pîrvu, Mihaela-Andreea Costache, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9371-9371
Open Access | Times Cited: 2
Best–worst scaling methodology to evaluate constructs of the Consolidated Framework for Implementation Research: application to the implementation of pharmacogenetic testing for antidepressant therapy
Ramzi G. Salloum, Jeffrey R. Bishop, Amanda L. Elchynski, et al.
Implementation Science Communications (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 10
The Genetics of Drug-Induced Qt Prolongation: Evaluating the Evidence for Pharmacodynamic Variants
Ana I Lopez-Medina, C. Anwar A. Chahal, Jasmine A. Luzum
Pharmacogenomics (2022) Vol. 23, Iss. 9, pp. 543-557
Open Access | Times Cited: 10
Human induced pluripotent stem cell–derived liver-on-a-chip for studying drug metabolism: the challenge of the cytochrome P450 family
Isabel Tamargo-Rubio, Anna Bella Simpson, Joanne A. Hoogerland, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 5
Unexpected High Need for Genetic Testing in Rheumatology: A Cross-Sectional Cohort Study
Lukas Kampik, Michael Schirmer
Genes (2023) Vol. 14, Iss. 10, pp. 1858-1858
Open Access | Times Cited: 5
Use of a multi-gene pharmacogenetic panel reduces adverse drug effects
Larisa H. Cavallari, Julie A. Johnson
Cell Reports Medicine (2023) Vol. 4, Iss. 5, pp. 101021-101021
Open Access | Times Cited: 5
Pharmacomicrobiomics and Drug–Infection Interactions: The Impact of Commensal, Symbiotic and Pathogenic Microorganisms on a Host Response to Drug Therapy
Norma Torres‐Carrillo, Erika Martínez‐López, Nora Magdalena Torres-Carrillo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 17100-17100
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top